By Brandon Boone Since the implementation of the FDA’s Foreign Supplier Verification Program (FSVP) in 2017, overall compliance rates have remained consistently low. There are a wide range of compliance levels—from firms that received Warning Letters to those that achieved No Action Indicated (NAI) outcomes. Based on these inspections, the following is a list of practical tips to help importers navigate the most common pitfalls. While not exhaustive, these recommendations can